Data on patients with systemic autoimmune disease and concomitant SARS-CoV-2 is limited, but reports have recently been released in Europe.5,6 In one case series, 10 SARS-CoV-2 positive BD patients were evaluated.4 Except one patient who was off treatment, all of the other nine were using one of the following drugs either alone or in combination: colchicine (n=5); azathioprine (n=3); anti-TNF agents (n=3); or prednisolone (n=2). The gene discussed is TNF; the disease is Behcet disease.